New prescriptions for stimulants among adults, largely to treat ADHD, have more than doubled since the start of the COVID-19 pandemic, especially in younger adults, finds new research published in CMAJ (Canadian Medical Association Journal).
Continue Reading
News Source: medicalxpress.com
Leave a Reply